🇺🇸 Iron Dextran Injection in United States

40 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 6 reports (15%)
  2. Pruritus — 5 reports (12.5%)
  3. Urticaria — 5 reports (12.5%)
  4. Back Pain — 4 reports (10%)
  5. Chest Pain — 4 reports (10%)
  6. Pyrexia — 4 reports (10%)
  7. Dizziness — 3 reports (7.5%)
  8. Fatigue — 3 reports (7.5%)
  9. Flushing — 3 reports (7.5%)
  10. Injection Site Discolouration — 3 reports (7.5%)

Source database →

Iron Dextran Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Iron Dextran Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Iron Dextran Injection in United States?

Menoufia University is the originator. The local marketing authorisation holder may differ — check the official source linked above.